Can smart pens and sensors tame diabetes? small study hopes to find out

NCT ID NCT04800471

Completed Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested whether using smart insulin pens together with continuous glucose monitors (CGMs) can improve blood sugar control in adults with type 2 diabetes. Thirty participants used these devices to track their glucose levels and insulin doses. The goal was to see if this technology helps lower HbA1c, a measure of average blood sugar over three months, and reduce dangerous low blood sugar episodes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Smart insulin pens and continuous glucose monitors (devices)
What this could lead to: If successful, this approach could help people with type 2 diabetes better manage their blood sugar levels and reduce complications.
What could go wrong: This is a small pilot study with only 30 participants, so results may not apply to everyone. The devices may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS

Contacts and locations

Locations

Baltimore VA Medical Center

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.